Imaging biomarkers for the treatment of esophageal cancer  

作　　者：Koichi Hayano Gaku Ohira Atsushi Hirata Tomoyoshi Aoyagi Shunsuke Imanishi Toru Tochigi Toshiharu Hanaoka Kiyohiko Shuto Hisahiro Matsubara 

机构地区：[1]Department of Frontier Surgery,Chiba University Graduate School of Medicine,Chiba 260-8677,Japan [2]Department of Surgery,Teikyo University Medical Center,Chiba 299-0111,Japan

出　　处：《World Journal of Gastroenterology》2019年第24期3021-3029,共9页世界胃肠病学杂志（英文版）

摘　　要：Esophageal cancer is known as one of the malignant cancers with poor prognosis.To improve the outcome,combined multimodality treatment is attempted.On the other hand,advances in genomics and other“omic”technologies are paving way to the patient-oriented treatment called“personalized”or“precision”medicine.Recent advancements of imaging techniques such as functional imaging make it possible to use imaging features as biomarker for diagnosis,treatment response,and prognosis in cancer treatment.In this review,we will discuss how we can use imaging derived tumor features as biomarker for the treatment of esophageal cancer.Esophageal cancer is known as one of the malignant cancers with poor prognosis.To improve the outcome, combined multimodality treatment is attempted. On the other hand, advances in genomics and other "omic" technologies are paving way to the patient-oriented treatment called "personalized" or "precision"medicine. Recent advancements of imaging techniques such as functional imaging make it possible to use imaging features as biomarker for diagnosis,treatment response, and prognosis in cancer treatment. In this review, we will discuss how we can use imaging derived tumor features as biomarker for the treatment of esophageal cancer.

关 键 词：Esophageal cancer Computed TOMOGRAPHY perfusion Dynamic-contrastenhanced magnetic resonance IMAGING Texture analysis DIFFUSION-WEIGHTED IMAGING POSITRON emission TOMOGRAPHY 

分 类 号：R[医药卫生]